Multi‐Omics Analysis of Aberrances and Functional Implications of IRF5 in Digestive Tract Tumours
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70433 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Long Yao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China. Hauptthemen laut MEDLINE: Interferon Regulatory Factors, Esophageal Neoplasms, Esophageal Squamous Cell Carcinoma, Adenocarcinoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Anhui Provincial Department of Education.
Abstract (Originalsprache)
Oesophageal cancer (EC) is a common gastrointestinal malignancy and includes oesophageal squamous cell carcinoma (ESCC) and oesophageal adenocarcinoma (EAC) sub‐types. Gene signatures predicting patient outcomes are not routinely used in clinical practice, particularly owing to batch effects and data standardisation. Here, we sought to establish and validate a reliable signature of senescence‐related genes (SRGs) that would aid in predicting prognosis in patients with EC. We downloaded transcriptomics data, and a novel pairwise comparison algorithm selected valid SRG pairs (SRGPs) to construct a prognostic SRGP signature. The SRGPs were verified using Kaplan–Meier survival and receiver operating characteristic curve analyses. Additionally, the relationships between the SRGP signatures and prognosis, immune cell infiltration and chemotherapeutic drug responsiveness were evaluated. The random forest algorithm identified the most clinically significant genes, followed by experimental validation. 19 and 26 SRGP signatures were created for ESCC ( n = 81) and EAC ( n = 79), respectively. Patients with EC were divided into two groups based on the median risk score. The Kaplan–Meier analysis demonstrated significant differences in overall survival between the ESCC and EAC groups ( p < 0.001). The sub‐types exhibited different immune signatures. IRF5 was the most clinically significant gene for ESCC. It was highly expressed in ESCC cells, and IRF5 knockdown inhibited cell migration and proliferation, while promoting apoptosis and senescence. The SRGP signature may predict prognosis and immunotherapeutic responses, and IRF5 is a potential target gene for ESCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
- Department of Cardiothoracic Surgery, Anhui No. 2 Provincial People's Hospital, Hefei, Anhui, China.
ORCID-Profile: Long Yao, Renquan Zhang
Förderung
- Anhui Provincial Department of Education
Zitieren
APA
Yao, L., Chen, X., Fang, Y., Huang, Y., Wu, K., Huang, X., Xu, J., & Zhang, R. (2025). Multi‐Omics Analysis of Aberrances and Functional Implications of IRF5 in Digestive Tract Tumours. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70433
Vancouver
Yao L, Chen X, Fang Y, Huang Y, Wu K, Huang X, et al. Multi‐Omics Analysis of Aberrances and Functional Implications of IRF5 in Digestive Tract Tumours. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70433
BibTeX
@article{Yao2025,
author = {Yao, Long and Chen, Xiu and Fang, Yanxin and Huang, Yunlong and Wu, Kaiming and Huang, Xin and Xu, Junrui and Zhang, Renquan},
title = {Multi‐Omics Analysis of Aberrances and Functional Implications of IRF5 in Digestive Tract Tumours},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70433}
}
EUVIMED